Guest guest Posted June 22, 2011 Report Share Posted June 22, 2011 http://news.consumerreports.org/health/2011/06/chantix-may-cause-heart-attacks.h\ tml Drug safety Chantix may cause heart attacks Jun 22, 2011 11:00 AM  The drug varenicline—sold under the brand name Chantix and used to help smokers quit—may increase the risk of heart problems, the FDA has warned. Varenicline more than doubles a smoker’s chance of quitting compared with willpower alone, but it has side effects. More than 1 in 10 people taking it feel nauseated, have trouble sleeping, get strange dreams, or get a headache. Some people have reported changes in mood or even suicidal feelings with the drug, although a 2009 study didn't find any link between varenicline and suicidal thoughts. Now, the Food and Drug Administration (FDA) has warned that varenicline may increase the risk of heart problems. In a year-long study of people trying to quit smoking, 2 in 100 people taking varenicline had a heart attack, compared with 1 in 100 people taking an inactive (placebo) treatment. And just over 2 in 100 people taking varenicline needed surgery to widen an artery and restore the blood flow to their heart, compared with 1 in 100 people taking a placebo. None of the people who had heart attacks died. The FDA based their warning on a good-quality study. However, even with 700 people taking part, the study may not be big enough to distinguish between a real increase in risk and random variation. To make sure the results aren’t a statistical fluke, the FDA has asked Pfizer (varenicline’s manufacturer) to combine data from all the available studies. This should give us a better idea of the side effects varenicline can cause, and the FDA promises an update when the research is complete. Bottom line: Smoking causes lots of health problems, including cancer, damage to blood vessels, and heart attacks. Even if varenicline does have some risks, they may be outweighed by the benefits of stopping smoking. Your doctor can help you weigh the risks and benefits. Alternatives to varenicline include bupropion and nicotine replacement products. You can report side effects of varenicline, or any drug, on the FDA's website. Source Chantix (varenicline) may increase the risk of certain cardiovascular adverse events in patients with cardiovascular disease [u.S. Food and Drug Administration] —Philip , BMJ Group ConsumerReportsHealth.org has partnered with The BMJ Group to monitor the latest medical research and assess the evidence to help you decide which news you should use Sent via BlackBerry by AT & T Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 22, 2011 Report Share Posted June 22, 2011 http://news.consumerreports.org/health/2011/06/chantix-may-cause-heart-attacks.h\ tml Drug safety Chantix may cause heart attacks Jun 22, 2011 11:00 AM  The drug varenicline—sold under the brand name Chantix and used to help smokers quit—may increase the risk of heart problems, the FDA has warned. Varenicline more than doubles a smoker’s chance of quitting compared with willpower alone, but it has side effects. More than 1 in 10 people taking it feel nauseated, have trouble sleeping, get strange dreams, or get a headache. Some people have reported changes in mood or even suicidal feelings with the drug, although a 2009 study didn't find any link between varenicline and suicidal thoughts. Now, the Food and Drug Administration (FDA) has warned that varenicline may increase the risk of heart problems. In a year-long study of people trying to quit smoking, 2 in 100 people taking varenicline had a heart attack, compared with 1 in 100 people taking an inactive (placebo) treatment. And just over 2 in 100 people taking varenicline needed surgery to widen an artery and restore the blood flow to their heart, compared with 1 in 100 people taking a placebo. None of the people who had heart attacks died. The FDA based their warning on a good-quality study. However, even with 700 people taking part, the study may not be big enough to distinguish between a real increase in risk and random variation. To make sure the results aren’t a statistical fluke, the FDA has asked Pfizer (varenicline’s manufacturer) to combine data from all the available studies. This should give us a better idea of the side effects varenicline can cause, and the FDA promises an update when the research is complete. Bottom line: Smoking causes lots of health problems, including cancer, damage to blood vessels, and heart attacks. Even if varenicline does have some risks, they may be outweighed by the benefits of stopping smoking. Your doctor can help you weigh the risks and benefits. Alternatives to varenicline include bupropion and nicotine replacement products. You can report side effects of varenicline, or any drug, on the FDA's website. Source Chantix (varenicline) may increase the risk of certain cardiovascular adverse events in patients with cardiovascular disease [u.S. Food and Drug Administration] —Philip , BMJ Group ConsumerReportsHealth.org has partnered with The BMJ Group to monitor the latest medical research and assess the evidence to help you decide which news you should use Sent via BlackBerry by AT & T Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 22, 2011 Report Share Posted June 22, 2011 http://news.consumerreports.org/health/2011/06/chantix-may-cause-heart-attacks.h\ tml Drug safety Chantix may cause heart attacks Jun 22, 2011 11:00 AM  The drug varenicline—sold under the brand name Chantix and used to help smokers quit—may increase the risk of heart problems, the FDA has warned. Varenicline more than doubles a smoker’s chance of quitting compared with willpower alone, but it has side effects. More than 1 in 10 people taking it feel nauseated, have trouble sleeping, get strange dreams, or get a headache. Some people have reported changes in mood or even suicidal feelings with the drug, although a 2009 study didn't find any link between varenicline and suicidal thoughts. Now, the Food and Drug Administration (FDA) has warned that varenicline may increase the risk of heart problems. In a year-long study of people trying to quit smoking, 2 in 100 people taking varenicline had a heart attack, compared with 1 in 100 people taking an inactive (placebo) treatment. And just over 2 in 100 people taking varenicline needed surgery to widen an artery and restore the blood flow to their heart, compared with 1 in 100 people taking a placebo. None of the people who had heart attacks died. The FDA based their warning on a good-quality study. However, even with 700 people taking part, the study may not be big enough to distinguish between a real increase in risk and random variation. To make sure the results aren’t a statistical fluke, the FDA has asked Pfizer (varenicline’s manufacturer) to combine data from all the available studies. This should give us a better idea of the side effects varenicline can cause, and the FDA promises an update when the research is complete. Bottom line: Smoking causes lots of health problems, including cancer, damage to blood vessels, and heart attacks. Even if varenicline does have some risks, they may be outweighed by the benefits of stopping smoking. Your doctor can help you weigh the risks and benefits. Alternatives to varenicline include bupropion and nicotine replacement products. You can report side effects of varenicline, or any drug, on the FDA's website. Source Chantix (varenicline) may increase the risk of certain cardiovascular adverse events in patients with cardiovascular disease [u.S. Food and Drug Administration] —Philip , BMJ Group ConsumerReportsHealth.org has partnered with The BMJ Group to monitor the latest medical research and assess the evidence to help you decide which news you should use Sent via BlackBerry by AT & T Quote Link to comment Share on other sites More sharing options...
Guest guest Posted June 22, 2011 Report Share Posted June 22, 2011 http://news.consumerreports.org/health/2011/06/chantix-may-cause-heart-attacks.h\ tml Drug safety Chantix may cause heart attacks Jun 22, 2011 11:00 AM  The drug varenicline—sold under the brand name Chantix and used to help smokers quit—may increase the risk of heart problems, the FDA has warned. Varenicline more than doubles a smoker’s chance of quitting compared with willpower alone, but it has side effects. More than 1 in 10 people taking it feel nauseated, have trouble sleeping, get strange dreams, or get a headache. Some people have reported changes in mood or even suicidal feelings with the drug, although a 2009 study didn't find any link between varenicline and suicidal thoughts. Now, the Food and Drug Administration (FDA) has warned that varenicline may increase the risk of heart problems. In a year-long study of people trying to quit smoking, 2 in 100 people taking varenicline had a heart attack, compared with 1 in 100 people taking an inactive (placebo) treatment. And just over 2 in 100 people taking varenicline needed surgery to widen an artery and restore the blood flow to their heart, compared with 1 in 100 people taking a placebo. None of the people who had heart attacks died. The FDA based their warning on a good-quality study. However, even with 700 people taking part, the study may not be big enough to distinguish between a real increase in risk and random variation. To make sure the results aren’t a statistical fluke, the FDA has asked Pfizer (varenicline’s manufacturer) to combine data from all the available studies. This should give us a better idea of the side effects varenicline can cause, and the FDA promises an update when the research is complete. Bottom line: Smoking causes lots of health problems, including cancer, damage to blood vessels, and heart attacks. Even if varenicline does have some risks, they may be outweighed by the benefits of stopping smoking. Your doctor can help you weigh the risks and benefits. Alternatives to varenicline include bupropion and nicotine replacement products. You can report side effects of varenicline, or any drug, on the FDA's website. Source Chantix (varenicline) may increase the risk of certain cardiovascular adverse events in patients with cardiovascular disease [u.S. Food and Drug Administration] —Philip , BMJ Group ConsumerReportsHealth.org has partnered with The BMJ Group to monitor the latest medical research and assess the evidence to help you decide which news you should use Sent via BlackBerry by AT & T Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.